This week, three medical devices stocks are improving their overall rating on Portfolio Grader. Each of these rates an “A” (“strong buy”) or “B” overall (“buy”).
This week, Winner Medical Group (WWIN) is making solid headway. The company’s rating improves to an A (“strong buy”) from last week’s B (“buy”) rating. Winner Medical Group engages in the research, development, manufacture, and marketing of cotton-base medical dressings and medical disposables. For more information, get Portfolio Grader’s complete analysis of WWIN stock.
Antares Pharma, Inc. (ATRS) ups its rating to a B (“buy”) this week after earning a C (“hold”) in the week before. Antares Pharma develops pharmaceutical delivery systems, including needle-free and mini-needle injector systems and transdermal gel technologies. For more information, get Portfolio Grader’s complete analysis of ATRS stock.
This week, Medtronic, Inc. (MDT) pushes up from a C to a B rating. Medtronic develops therapeutic and diagnostic medical products. For more information, get Portfolio Grader’s complete analysis of MDT stock.
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.